Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.

Hauser SL, Bar-Or A, Weber MS, Kletzl H, Günther A, Manfrini M, Model F, Mercier F, Petry C, Wing Q, Koendgen H, Smith T, Kappos L.